Yeah, I think in the future we’re going to have to probably be a bit more standardized and meticulous in how we record and capture the physical aspects of treatment, so the dose, the volume, and all of these metrics. But I think then we’re going to be more cognizant, for example, as I’m interested in the sex of the patients, so are we treating a female patient, a male patient and what that means biologically...
Yeah, I think in the future we’re going to have to probably be a bit more standardized and meticulous in how we record and capture the physical aspects of treatment, so the dose, the volume, and all of these metrics. But I think then we’re going to be more cognizant, for example, as I’m interested in the sex of the patients, so are we treating a female patient, a male patient and what that means biologically. So I think in the future we probably will have a bit more biological tests that we can run to tell us how much recovery has occurred and inform how we should treat these patients. So I think there’s definitely in the near future going to be a bit more biology in the MDG room and that’s how I close my argument actually in the debate.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.